Delivered as a Hybrid Event
April 28-30, 2025The Ritz-Carlton, Tysons Corner | McLean, VA Amy WilsonVice President, Chief Compliance Officer at Esperion TherapeuticsSpeaker
Profile
Amy Wilson is VP, Chief Compliance Officer for Esperion Therapeutics, a pharmaceutical company specializing in specialty cardiovascular products. She has over 30 years of experience in the life science industry; beginning her career in sales and marketing and transitioning to escalating compliance roles over the past 10 years. Amy has an MBA from Fairleigh Dickinson University and a Master’s in Law from Seton Hall Law. She especially enjoys opportunities to partner with the business on innovative programs that require fresh thinking around applicable principles and guardrails.
Agenda Sessions
Off-Label Communication: Compliance and Governance Implications of Scientific Information for Unapproved Use (SIUU)
, 4:45pmView Session